Immunodiagnosis and Molecular Validation of Toxoplasma Gondii-Recombinant Dense Granular (Gra) 5 Protein for the Detection of Toxoplasmosis in Hemodialysis Patients Publisher Pubmed



Arabmazar Z^{1, 2} ; Javadi Mamaghani A³ ; Fallahi S^{4, 5} ; Rajaeian S⁶ ; Koochaki A⁷ ; Seyyed Tabaei SJ³ ; Rezaee H⁸ Show Affiliations
Source: Seminars in Dialysis Published:2021

Abstract

Toxoplasmosis causes serious complications in immunocompromised and pregnant women. Serological tests for the detection of toxoplasmosis are often designed from parasitic tachyzoites antigens. The process of producing these antigens is very difficult. The purpose of this study was evaluation of T. gondii-rGRA5 for the immunodiagnosis and molecular detection of Toxoplasma infection using enzyme-linked immunosorbent assay (ELISA) and LAMP methods in hemodialysis patients. The GRA5 gene was successfully expressed and purified by affinity chromatography assay and evaluated by western blot. Then it was used to design an ELISA assay. A total of 260 samples were tested for anti-Toxoplasma IgG and IgM antibodies using a commercial ELISA kit and designed ELISA kit. Finally, the LAMP method was used to evaluate the precision and reliability of the results obtained by commercial and designed ELISA kits. The consistency of the results of two methods was analyzed using the Kappa coefficient of agreement. The rGRA5 revealed higher immunoreactivity with 1:100 dilution of sera from toxoplasmosis patients. The specificity and sensitivity of the assay were 93% and 96%, respectively. According to the Kappa coefficient, there was a substantial correlation between the results of ELISA and LAMP based on rGRA5 (≈98%, p < 0.001). Also it showed that rGRA5 protein can be used as an antigenic protein for designing sero-diagnostic tests to identify Toxoplasma infection especially in hemodialysis patients. © 2021 Wiley Periodicals LLC.